Millions of people in China and other countries have already received this vaccine. Previously, WHO only approved vaccines
Because at an early stage internationallylittle data has been published, and the effectiveness of Chinese vaccines has long been uncertain. But on Friday, the WHO said it had confirmed the “safety, effectiveness and quality” of the Sinopharm vaccine, developed by the Beijing Institute of Biological Products.
WHO said approval of this vaccine has"The potential to rapidly accelerate access to COVID-19 vaccine for countries seeking to protect healthcare workers and populations at risk." WHO recommends that the vaccine be given in two doses for people 18 years of age and older.
Sputnik Light is registered in the Russian Federation. The vaccine is effective against new strains of coronavirus
The endorsement from WHO is the setting for nationalregulatory authorities confirming the safety and efficacy of the vaccine. WHO Director-General Tedros Adhanom Ghebreyesus said this would give countries "confidence that they can expedite the approval process for their regulations."
This also means that the vaccine can beuse in the global COVAX program, which was created last year to ensure equitable access to vaccines for rich and poor countries. The decision to list the Chinese vaccine for emergency use is expected to give a significant boost to this program, which is experiencing supply problems.
Read on:
- Look at the photo of a Chinese rocket falling to Earth
- Scientists have conducted the largest genetic study of super-longevity
- The intensity of the new powerful laser is comparable to the light of the Sun falling on the Earth